Work

SWOG 0204; Phase 2 Trial of Thalidomide (T) + Dexamethasone (D) Induction Followed by Tandem Autotransplant (TAT) and Prednisone (P) + T Maintenance for Multiple Myeloma (MM).

Year: 2005

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v106.11.1169.1169

Authors: Mohamad A. Hussein, Jason McCoy, Andrzej Jakubowiak, Brian G. Durie, John J. Crowley, Bart Barlogie

Institutions: Cleveland Clinic, University of Michigan, Cedars-Sinai Medical Center, University of Arkansas for Medical Sciences

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2566262734

FWCI: 0.779

Cites:

Cited by: 4

Related to: 10